Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Delirium | 8 | 2022 | 207 | 3.090 |
Why?
|
| Palliative Care | 28 | 2020 | 2037 | 2.700 |
Why?
|
| Hospital Mortality | 8 | 2018 | 1274 | 1.770 |
Why?
|
| Cancer Care Facilities | 11 | 2020 | 884 | 1.650 |
Why?
|
| Emergency Service, Hospital | 11 | 2022 | 1148 | 1.540 |
Why?
|
| Dyspnea | 9 | 2022 | 416 | 1.420 |
Why?
|
| Neoplasms | 26 | 2022 | 15193 | 1.240 |
Why?
|
| Intensive Care Units | 4 | 2016 | 717 | 1.060 |
Why?
|
| Length of Stay | 9 | 2021 | 1900 | 0.890 |
Why?
|
| Hospice and Palliative Care Nursing | 2 | 2020 | 56 | 0.860 |
Why?
|
| Hospice Care | 3 | 2020 | 156 | 0.760 |
Why?
|
| Death | 2 | 2020 | 119 | 0.710 |
Why?
|
| Terminal Care | 4 | 2020 | 447 | 0.670 |
Why?
|
| Hospitalization | 8 | 2022 | 2083 | 0.630 |
Why?
|
| Critical Illness | 2 | 2013 | 714 | 0.590 |
Why?
|
| Haloperidol | 1 | 2017 | 64 | 0.590 |
Why?
|
| Advance Directives | 1 | 2017 | 88 | 0.570 |
Why?
|
| Cultural Diversity | 1 | 2016 | 76 | 0.560 |
Why?
|
| Empathy | 1 | 2016 | 101 | 0.530 |
Why?
|
| Respiratory System Agents | 1 | 2015 | 9 | 0.530 |
Why?
|
| Milrinone | 1 | 2015 | 33 | 0.520 |
Why?
|
| Antipsychotic Agents | 2 | 2017 | 414 | 0.520 |
Why?
|
| Resuscitation Orders | 1 | 2015 | 68 | 0.500 |
Why?
|
| Oncologists | 1 | 2016 | 134 | 0.490 |
Why?
|
| Referral and Consultation | 3 | 2018 | 899 | 0.470 |
Why?
|
| Patient Discharge | 3 | 2018 | 661 | 0.460 |
Why?
|
| Health Services Accessibility | 2 | 2016 | 761 | 0.430 |
Why?
|
| Hemoptysis | 1 | 2011 | 36 | 0.410 |
Why?
|
| Cough | 1 | 2011 | 116 | 0.380 |
Why?
|
| Attitude of Health Personnel | 2 | 2015 | 918 | 0.370 |
Why?
|
| Hypnotics and Sedatives | 2 | 2008 | 218 | 0.360 |
Why?
|
| Benzodiazepines | 1 | 2010 | 170 | 0.340 |
Why?
|
| Mental Recall | 1 | 2009 | 171 | 0.320 |
Why?
|
| Respiratory Tract Neoplasms | 1 | 2007 | 37 | 0.300 |
Why?
|
| Critical Care | 3 | 2010 | 770 | 0.290 |
Why?
|
| Humans | 46 | 2022 | 261506 | 0.290 |
Why?
|
| Physicians | 1 | 2015 | 882 | 0.280 |
Why?
|
| Middle Aged | 26 | 2020 | 86204 | 0.260 |
Why?
|
| Family | 2 | 2020 | 736 | 0.250 |
Why?
|
| Lung Neoplasms | 2 | 2020 | 11538 | 0.240 |
Why?
|
| Physician's Role | 1 | 2006 | 238 | 0.240 |
Why?
|
| Quality of Health Care | 2 | 2020 | 621 | 0.240 |
Why?
|
| Methadone | 1 | 2005 | 195 | 0.240 |
Why?
|
| Aged | 20 | 2018 | 70117 | 0.230 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2007 | 544 | 0.230 |
Why?
|
| Female | 29 | 2020 | 141928 | 0.230 |
Why?
|
| Male | 28 | 2022 | 123000 | 0.230 |
Why?
|
| Medication Errors | 1 | 2005 | 174 | 0.230 |
Why?
|
| Prospective Studies | 6 | 2022 | 12873 | 0.230 |
Why?
|
| Caregivers | 1 | 2009 | 677 | 0.220 |
Why?
|
| Patient-Centered Care | 1 | 2006 | 294 | 0.220 |
Why?
|
| Stress, Psychological | 2 | 2011 | 1000 | 0.220 |
Why?
|
| Alcoholism | 1 | 2005 | 285 | 0.220 |
Why?
|
| Patient Admission | 1 | 2004 | 220 | 0.220 |
Why?
|
| Respiratory Insufficiency | 1 | 2005 | 330 | 0.210 |
Why?
|
| Analgesics, Opioid | 3 | 2015 | 1371 | 0.210 |
Why?
|
| Acute Pain | 1 | 2022 | 42 | 0.200 |
Why?
|
| Heart Failure | 1 | 2015 | 2516 | 0.200 |
Why?
|
| Inpatients | 3 | 2018 | 678 | 0.190 |
Why?
|
| Carotid Artery Diseases | 1 | 2022 | 196 | 0.180 |
Why?
|
| Texas | 7 | 2011 | 6311 | 0.170 |
Why?
|
| Health Care Rationing | 1 | 2020 | 94 | 0.170 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2008 | 1303 | 0.170 |
Why?
|
| Pain, Intractable | 2 | 2011 | 171 | 0.150 |
Why?
|
| Retrospective Studies | 12 | 2021 | 37905 | 0.150 |
Why?
|
| Logistic Models | 2 | 2018 | 3441 | 0.150 |
Why?
|
| Risperidone | 1 | 2017 | 62 | 0.150 |
Why?
|
| Oxygen | 1 | 2020 | 754 | 0.140 |
Why?
|
| Aged, 80 and over | 10 | 2016 | 29902 | 0.140 |
Why?
|
| Treatment Outcome | 2 | 2015 | 32848 | 0.140 |
Why?
|
| China | 1 | 2017 | 606 | 0.140 |
Why?
|
| Medical Oncology | 2 | 2017 | 1423 | 0.130 |
Why?
|
| Minority Groups | 1 | 2016 | 322 | 0.120 |
Why?
|
| Adult | 13 | 2016 | 77950 | 0.120 |
Why?
|
| United States | 4 | 2020 | 15433 | 0.110 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 860 | 0.110 |
Why?
|
| Fatal Outcome | 3 | 2012 | 829 | 0.110 |
Why?
|
| Young Adult | 5 | 2016 | 21445 | 0.110 |
Why?
|
| Anesthetics, Dissociative | 1 | 2012 | 22 | 0.110 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 2012 | 31 | 0.110 |
Why?
|
| Prognosis | 4 | 2019 | 21713 | 0.100 |
Why?
|
| Pain Management | 2 | 2022 | 668 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2012 | 179 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2012 | 402 | 0.090 |
Why?
|
| Injections, Subcutaneous | 1 | 2010 | 334 | 0.090 |
Why?
|
| Professional-Family Relations | 1 | 2011 | 134 | 0.090 |
Why?
|
| Hospital Units | 1 | 2009 | 38 | 0.090 |
Why?
|
| Ketamine | 1 | 2012 | 234 | 0.080 |
Why?
|
| Chlorpromazine | 1 | 2008 | 17 | 0.080 |
Why?
|
| Risk Factors | 3 | 2018 | 17523 | 0.080 |
Why?
|
| Lorazepam | 1 | 2008 | 40 | 0.080 |
Why?
|
| Midazolam | 1 | 2008 | 75 | 0.080 |
Why?
|
| ras Proteins | 1 | 2012 | 770 | 0.080 |
Why?
|
| Conscious Sedation | 1 | 2008 | 104 | 0.080 |
Why?
|
| Social Support | 1 | 2011 | 560 | 0.080 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2010 | 164 | 0.080 |
Why?
|
| Oncology Service, Hospital | 1 | 2007 | 48 | 0.080 |
Why?
|
| Translocation, Genetic | 1 | 2012 | 1245 | 0.070 |
Why?
|
| Survival Analysis | 3 | 2020 | 9180 | 0.070 |
Why?
|
| Methylprednisolone | 1 | 2007 | 193 | 0.070 |
Why?
|
| Head and Neck Neoplasms | 1 | 2022 | 3976 | 0.070 |
Why?
|
| Leukemia | 1 | 2015 | 1635 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2018 | 9244 | 0.070 |
Why?
|
| Back Pain | 1 | 2005 | 61 | 0.070 |
Why?
|
| Sertraline | 1 | 2005 | 45 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2011 | 1171 | 0.070 |
Why?
|
| Hyperalgesia | 1 | 2007 | 238 | 0.060 |
Why?
|
| Adolescent | 5 | 2021 | 31252 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2005 | 553 | 0.060 |
Why?
|
| Hospitals, University | 1 | 2004 | 209 | 0.060 |
Why?
|
| Reimbursement Mechanisms | 1 | 2004 | 78 | 0.060 |
Why?
|
| Drug Monitoring | 1 | 2005 | 333 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2012 | 2488 | 0.060 |
Why?
|
| Medical Records | 1 | 2004 | 415 | 0.050 |
Why?
|
| Dexamethasone | 1 | 2007 | 1450 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2009 | 4298 | 0.050 |
Why?
|
| Carotid Arteries | 1 | 2022 | 240 | 0.050 |
Why?
|
| Health Planning | 1 | 2020 | 26 | 0.050 |
Why?
|
| Pain | 1 | 2008 | 1658 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2000 | 181 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2020 | 460 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 4938 | 0.040 |
Why?
|
| Loss of Heterozygosity | 1 | 2000 | 602 | 0.040 |
Why?
|
| Syndrome | 1 | 2022 | 1351 | 0.040 |
Why?
|
| Health Care Surveys | 2 | 2010 | 430 | 0.040 |
Why?
|
| Neoplasm Staging | 2 | 2010 | 13658 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2022 | 712 | 0.040 |
Why?
|
| Health Care Costs | 1 | 2022 | 674 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 524 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 14889 | 0.030 |
Why?
|
| Esophageal Neoplasms | 2 | 2000 | 3168 | 0.030 |
Why?
|
| Stents | 1 | 2022 | 1096 | 0.030 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 1998 | 388 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2020 | 2588 | 0.030 |
Why?
|
| Health Personnel | 1 | 2020 | 625 | 0.030 |
Why?
|
| Alleles | 1 | 2000 | 2437 | 0.030 |
Why?
|
| Telemedicine | 1 | 2020 | 471 | 0.030 |
Why?
|
| Laryngeal Neoplasms | 1 | 1998 | 518 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2004 | 4320 | 0.030 |
Why?
|
| Advance Directive Adherence | 1 | 2012 | 1 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2000 | 5437 | 0.030 |
Why?
|
| Tongue Diseases | 1 | 2012 | 17 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 2008 | 4638 | 0.030 |
Why?
|
| Angioedema | 1 | 2012 | 21 | 0.030 |
Why?
|
| Mutation | 1 | 2012 | 15179 | 0.030 |
Why?
|
| Anesthetics, Intravenous | 1 | 2012 | 73 | 0.030 |
Why?
|
| Nursing Homes | 1 | 2012 | 99 | 0.030 |
Why?
|
| Hydroxyurea | 1 | 2012 | 204 | 0.030 |
Why?
|
| Fentanyl | 1 | 2012 | 148 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2012 | 14289 | 0.020 |
Why?
|
| Pandemics | 1 | 2020 | 1559 | 0.020 |
Why?
|
| Medical Audit | 1 | 2011 | 188 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 15694 | 0.020 |
Why?
|
| Hospices | 1 | 2010 | 51 | 0.020 |
Why?
|
| Probability | 1 | 2011 | 866 | 0.020 |
Why?
|
| Airway Obstruction | 1 | 2012 | 261 | 0.020 |
Why?
|
| Patient Care Management | 1 | 2010 | 94 | 0.020 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2010 | 211 | 0.020 |
Why?
|
| Neoplasms, Second Primary | 1 | 1998 | 1350 | 0.020 |
Why?
|
| Algorithms | 1 | 2020 | 3890 | 0.020 |
Why?
|
| Psychotherapy | 1 | 2011 | 247 | 0.020 |
Why?
|
| Analgesics | 1 | 2011 | 390 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2007 | 133 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2009 | 414 | 0.020 |
Why?
|
| Demography | 1 | 2007 | 435 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2011 | 795 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 1331 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2007 | 244 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2009 | 1546 | 0.020 |
Why?
|
| Emotions | 1 | 2008 | 562 | 0.020 |
Why?
|
| Models, Biological | 1 | 2010 | 3254 | 0.010 |
Why?
|
| Age Factors | 1 | 2010 | 5377 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2000 | 575 | 0.010 |
Why?
|
| Epiglottis | 1 | 1998 | 12 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2000 | 1471 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2000 | 1442 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2000 | 1450 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2000 | 3203 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 1998 | 4844 | 0.010 |
Why?
|